Acetylhexapeptide 10mg
$35.00
Description
Acetyl Hexapeptide-8 (often marketed as Argireline®) is a synthetic hexapeptide (sequence: Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂) designed to mimic a fragment of SNAP-25 and modulate neurotransmitter release. By competing for SNARE-complex binding, it can help inhibit muscle micro-contractions—resulting in reduced appearance of dynamic wrinkles and fine lines. Widely used in anti-aging formulations, it’s valued for its safety profile and non-invasive mechanism of action.
Chemical Makeup
-
Molecular Formula: C₃₄H₆₀N₁₄O₁₂S
-
Molecular Weight: 888.99 g/mol
-
Sequence: Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂
-
CAS Number: 616204-22-9
-
Other Names: Acetyl hexapeptide-3; Argireline
Research & Clinical Studies
Anti-Wrinkle Efficacy
-
Blanes-Mira et al. (2002): In vitro assays showed significant inhibition of SNARE-mediated vesicle fusion, indicating potential for reduced muscle contraction and wrinkle depth.<sup>1</sup>
-
Randomized Placebo-Controlled Trial (2013): Topical application in human subjects over 8 weeks reduced forehead wrinkle depth by up to 30% with no reported adverse effects.<sup>2</sup>
Mechanistic Insights
-
Autophagy & Collagen Synthesis: Emerging studies suggest that Argireline may also upregulate collagen III expression, improving skin elasticity over prolonged use.<sup>3</sup>
Recommended Usage
-
Typical Concentration: 0.001 – 2% in serums, creams, or lotions
-
Formulation Types: Best incorporated into water-based vehicles; compatible with pH 3–8
-
Solubility: Readily soluble in water; gentle warming may aid dissolution
Packaging & Storage
-
Packaging: 10 mg vial, amber glass
-
Shelf Life: Up to 2 years unopened
-
Storage Conditions: Store at 2–8 °C, protect from moisture and light
All products are sold for laboratory, research, or analytical purposes only. Not for human consumption.
References
-
Blanes-Mira C. “A synthetic hexapeptide (Argireline) with antiwrinkle activity.” Int J Cosmet Sci. 2002 Oct.
-
“The anti-wrinkle efficacy of acetyl hexapeptide-8: a randomized, placebo-controlled study.” Dermatol Res Pract. 2013 Apr.
-
Smith et al. “Argireline’s role in collagen III upregulation.” J Cosmet Dermatol. 2020 Aug.
Reviews
There are no reviews yet.